![Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-93294-6/MediaObjects/41598_2021_93294_Fig1_HTML.png)
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports
![Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02822/article_deploy/html/images/diagnostics-12-02822-g001.png?1668597237)
Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area
![Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience | Swiss Medical Weekly Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience | Swiss Medical Weekly](https://smw.ch/index.php/smw/article/download/2614/version/2614/4134/12511/2120723120597238828_w20077_f3_conv.jpg)
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience | Swiss Medical Weekly
Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study | PLOS ONE
![Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement](https://www.frontiersin.org/files/Articles/739875/fendo-12-739875-HTML/image_m/fendo-12-739875-t005.jpg)
Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement
![Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard | BMC Pediatrics | Full Text Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard | BMC Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12887-019-1485-8/MediaObjects/12887_2019_1485_Fig2_HTML.png)
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard | BMC Pediatrics | Full Text
![Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8046a3d8-0826-4836-b9c0-176a65022080/hepr13821-fig-0002-m.png)
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library
![Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram](https://www.researchgate.net/publication/339994413/figure/fig1/AS:870246873317377@1584494431520/Hepatic-steatosis-on-FibroScan-with-controlled-attenuation-parameter-CAP-S0-CAP-233.png)
Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram
![Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | Digestive Diseases and Sciences Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | Digestive Diseases and Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10620-019-05702-7/MediaObjects/10620_2019_5702_Fig1_HTML.png)
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | Digestive Diseases and Sciences
![Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience](https://smw.ch/index.php/smw/article/download/2614/version/2614/4134/12506/2120723120630201160_w20077_f4_conv.jpg)
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
![Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu](https://journals.sagepub.com/cms/10.1177/0300060520903667/asset/images/large/10.1177_0300060520903667-fig4.jpeg)